Definium to present Phase 3 data on lysergide tablet at NEI congress
Tweet Send to a Friend
Definium Therapeutics (NASDAQ: DFTX) announced it will present four posters at the 2026 NEI Fall Congress in Colorado Springs, Colo ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




